|
1. (Journal Article): Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential.
Holst JJ ABSTRACT:
Glucagon-like peptide-1 (GLP-1) is an insulinotropic hormone secreted from endocrine cells in the gut mucosa in response to meal ingestion. It is an important incretin hormone; mic...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T2DM
»
Insulinotropic Subst...
»
Incretins
»
GLP-1
»
Journal Article
submitted: Nov 16, 2005 |
|
2. (Journal Article): Glucagon and other proglucagon-derived peptides. Gut peptides: biochemistry and physiology
Holst JJ, 0rskov C ABSTRACT:
n.a.
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Anti-Hyperglycemic a...
»
Incretin Hormones
»
GLP-1
»
Journal Article
submitted: Nov 24, 2005 |
|
3. (Journal Article): Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.
Holst JJ, Deacon CF ABSTRACT:
n.a.
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Anti-Hyperglycemic a...
»
Incretin Hormones
»
GLP-1
»
Effectivity of GLP-1...
»
Degradation by Dipep...
»
Dipeptidyl-Peptidase...
»
Journal Article
submitted: Nov 29, 2005 |
|
4. (Journal Article): GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans.
Schjoldager BT, Mortensen PE, Christiansen J, 0rskov C, Holst JJ ABSTRACT:
Glucagon-like peptide 1 amide (GLP-1 amide), a predicted product of the glucagon gene (proglucagon 72-107-amide), and truncated GLP-1 (proglucagon 78-107-amide), recently isolated ...
|
»
Diabetes OD
»
Development and Func...
»
Pancreas
»
Incretin Hormones
»
GLP-1
»
Journal Article
submitted: Nov 24, 2005 |
|
5. (Journal Article): Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.
Zander M, Madsbad S, Madsen JL, Holst JJ ABSTRACT:
BACKGROUND: Glucagon-like peptide 1 (GLP-1) has been proposed as a treatment for type 2 diabetes. We have investigated the long-term effects of continuous administration of this pe...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T2DM
»
Insulinotropic Subst...
»
Incretins
»
GLP-1
»
Journal Article
submitted: Nov 19, 2005 |
|
6. (Journal Article): Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.
Deacon CF, Johnsen AH, Holst JJ ABSTRACT:
The metabolism of glucagon-like peptide-1 (GLP-1) has not been studied in detail, but it is known to be rapidly cleared from the circulation. Measurement by RIA is hampered by the ...
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Anti-Hyperglycemic a...
»
Incretin Hormones
»
GLP-1
»
Effectivity of GLP-1...
»
Degradation by Dipep...
»
Journal Article
submitted: Nov 24, 2005 |
|
7. (Journal Article): Proglucagon processing in porcine and human pan-creas.
Holst JJ, Bersani M, Johnsen AH, Kofod H, Hartmann B, Orskov C ABSTRACT:
In the pancreas proglucagon (PG), a peptide precursor of 160 amino acids is cleaved to produce glucagon and a 30-amino acid N-terminal flanking peptide, but the fate of the C-termi...
|
»
Diabetes OD
»
Development and Func...
»
Pancreas
»
Islet Cells
»
Beta-Cells
»
Insulin Secretion
»
Proglucagon Processi...
»
Journal Article
submitted: Sep 01, 2005 |
|
8. (Journal Article): Pancreatic and intestinal processing of proglucagon in man.
0rskov C, Holst JJ, Poulsen S, Kirkegaard P ABSTRACT:
We developed antisera and radioimmunoassays against synthetic replicas of glucagon-like peptide-1 (1-36) and -2, predicted products of the glucagon precursor, and against glucagon-...
|
»
Diabetes OD
»
Development and Func...
»
Pancreas
»
Incretin Hormones
»
GLP-1
»
Journal Article
submitted: Nov 24, 2005 |
|